<DOC>
	<DOC>NCT00486798</DOC>
	<brief_summary>The purpose of this study is to compare the efficacy of quetiapine IR, following rapid titration versus conventional titration in patients with acute psychosis</brief_summary>
	<brief_title>FAST-A Study to Evaluate the Efficacy and Safety of Quetiapin IR in Patients With Acute Psychosis</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>provision of written informed consent male or female, aged 1865 years requirement of hospitalization and in need for antipsychotic treatment for an acute psychotic episode able to swallow tablets from Day 1 Inpatients who are anticipated to be discharged before evaluation of the primary outcome variable at Day 5 patients with known relevant clinical disease history of syncope, or orthostatic hypotension patients with known neutropenia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>acute schizophrenia</keyword>
	<keyword>schizoaffective disorder</keyword>
	<keyword>psychosis Not Otherwise Specified (NOS)</keyword>
	<keyword>bipolar mania with psychotic symptoms</keyword>
</DOC>